Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
McKesson
Chinese Patent Office
McKinsey
Baxter
Fuji
Accenture
Dow
Argus Health

Generated: July 17, 2018

DrugPatentWatch Database Preview

LYGEN Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Lygen, and what generic alternatives are available?

Lygen is a drug marketed by Alra and is included in three NDAs.

The generic ingredient in LYGEN is chlordiazepoxide hydrochloride. There are eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the chlordiazepoxide hydrochloride profile page.
Summary for LYGEN
Drug patent expirations by year for LYGEN
Synonyms for LYGEN
(7-CHLORO-4-OXY-5-PHENYL-3H-BENZO[E][1,4]DIAZEPIN-2-YL)-METHYL-AMINE
3H-1,4-Benzodiazepin-2-amine, 7-chloro-N-methyl-5-phenyl-, 4-oxide
3H-1,4-Benzodiazepin-2-amine, 7-chloro-N-methyl-5-phenyl, 4-oxide
3H-1,4-benzodiazepin-2-amine,7-chloro-N-methyl-5-phenyl-,4-oxide
3H-1,4-Benzodiazepine, 7-chloro-2-(methylamino)-5-phenyl-, 4-oxide
58-25-3
6RZ6XEZ3CR
7-Chlor-2-methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxid
7-Chlor-2-methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxid [German]
7-Chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine 4-oxide
7-chloro-2-(methylamino)-5-phenyl-3H-benzo[e][1,4]diazepine 4-oxide
7-Chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide
7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine
7-chloro-N-methyl-4-oxido-5-phenyl-3H-1,4-benzodiazepin-4-ium-2-amine
7-Chloro-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-amine 4-oxide
7-Chloro-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2amine-4-oxide
7-Cloro-2-metilamino-5-fenil-3H-1,4-benzodiazepina 4-ossido
7-Cloro-2-metilamino-5-fenil-3H-1,4-benzodiazepina 4-ossido [Italian]
A-Poxide
AB00053219-06
AB06298
Abboxide
AC-13012
AC1L1EAN
AK116456
AKOS005518509
AKOS015963131
AN-23598
ANTSCNMPPGJYLG-UHFFFAOYSA-N
API0000465
Apo-Chlordiazepoxide
Azepoxide-d5
Balance
Balance (pharmaceutical)
BBL010791
BDBM50007664
Bio-0792
C16H14ClN3.H2O
CAS-58-25-3
CCG-101136
CHEBI:3611
CHEBI:94781
CHEMBL451
Chloradiazepoxide
Chlordiazachel
Chlordiazepoxid
chlordiazepoxide
Chlordiazepoxide (JP15/USP/INN)
Chlordiazepoxide (JP17/USP/INN)
Chlordiazepoxide [USAN:INN:BAN:JAN]
Chlordiazepoxide 1.0 mg/ml in Methanol
Chlordiazepoxide Base
Chlordiazepoxide Hcl
chlordiazepoxide-hcl
Chlordiazepoxidum
Chlordiazepoxidum [INN-Latin]
Chlordiazepoxydum
Chloridazepoxide
Chloridiazepide
Chloridiazepoxide
Chlorodiazepoxide
Chlozepid
Clopoxide
Clordiazepossido
Clordiazepossido [Italian]
Clordiazepoxido
Clordiazepoxido [INN-Spanish]
Control
CPD000469226
D00267
D06BEP
DB00475
DEA No. 2744
Decacil
Disarim
DivK1c_000995
DSSTox_CID_26022
DSSTox_GSID_46022
DSSTox_RID_81295
DTXSID4046022
Eden
Eden-psich
EINECS 200-371-0
Elenium
FT-0631257
GTPL3370
HE004469
HE356026
Helogaphen
HMS2052C19
HMS2231M10
HMS3373M10
HMS3394C19
HMS503G11
HSDB 3028
I06-0193
IDI1_000995
Ifibrium
Kalmocaps
KBio1_000995
KBioGR_001016
Librax
Librelease
Librinin
Librinin|||Silibrin
Libritabs
Libritabs (TN)
Librium
Librium (TN)
LS-168455
LS-34063
Menrium
MENRIUM 10-4
MENRIUM 5-4
Mesural
Methaminodiazepoxide
Mildmen
MLS001066622
MLS001424220
MLS003899195
MolPort-002-051-367
Multum
Napoton
Napton
NC00386
NCGC00246347-01
NINDS_000995
Novapam (TN)
Novo-Poxide
Psicosan
Radepur
Risolid
SAM001246815
SCHEMBL145243
SCHEMBL18474
Silibrin
SMR000469226
Sonimen
SPBio_001113
Spectrum2_001157
Spectrum4_000578
Spectrum5_001623
STK597142
Tox21_111567
Tox21_111568
Tropium
Tropium (TN)
UNII-6RZ6XEZ3CR
Viopsicol
W-105404
Zeisin
Zetran
ZINC19632917

US Patents and Regulatory Information for LYGEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alra LYGEN chlordiazepoxide hydrochloride CAPSULE;ORAL 085107-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alra LYGEN chlordiazepoxide hydrochloride CAPSULE;ORAL 085009-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alra LYGEN chlordiazepoxide hydrochloride CAPSULE;ORAL 085108-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
McKinsey
Cipla
US Army
Harvard Business School
AstraZeneca
Medtronic
Argus Health
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.